Instituto D'Or de Pesquisa e Ensino - Sao Paulo
Instituto D'Or de Pesquisa e Ensino - Sao Paulo
Av. República do Líbano, 611 - Ibirapuera, São Paulo - SP, 04501-000
Select an option
I am a doctor
I am a sponsor
Open studies
Non-Hodgkin Lymphoma
An Open-Label Study Comparing Glofitamab and Polatuzumab Vedotin + Rituximab, Cyclophosphamide, Doxorubicin, and Prednisone Versus Pola-R-CHP in Previously Untreated Patients With Large B-Cell Lymphoma - GO44145 - Hoffmann-La RocheSee more
A Study to Evaluate Glofitamab as a Single Agent vs. Investigator's Choice in Participants With Relapsed/Refractory Mantle Cell Lymphoma - GLOBRYTE - Hoffmann-La RocheSee more
Study to Compare the Effectiveness and Safety of Golcadomide Plus R-CHOP vs Placebo Plus R-CHOP in Participants With Previously Untreated High-risk Large B-cell Lymphoma - GOLSEEK-1 - CelgeneSee more
A Dose-Escalation and Expansion Study of BGB-16673 in Participants With B-Cell Malignancies - CaDAnCe-101 - BeiGeneSee more
A Trial to Learn How Effective and Safe Odronextamab is Compared to Standard of Care for Adult Participants With Previously Treated Aggressive B-cell Non-Hodgkin Lymphoma - OLYMPIA-4 - Regeneron PharmaceuticalsSee more
Leukemia
A Dose-Escalation and Expansion Study of BGB-16673 in Participants With B-Cell Malignancies - CaDAnCe-101 - BeiGeneSee more
A Phase 1/2 Study of Bleximenib in Participants With Acute Leukemia (cAMeLot-1) - cAMeLot-1 - Janssen Research & Development, LLCSee more
A Study to Investigate Progression-Free Survival With Sonrotoclax Plus Obinutuzumab Or Sonrotoclax Plus Rituximab Compared With Venetoclax Plus Rituximab Treatment In Patients With Relapsed and/or Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CELESTIAL-RRCLL) - CELESTIAL-RRCLL - German CLL Study GroupSee more
A Study of Bleximenib, Venetoclax and Azacitidine For Treatment of Participants With Acute Myeloid Leukemia (AML) - cAMeLot-2 - Janssen Research & Development, LLCSee more
Breast Cancer
A Study of Imlunestrant Versus Standard Endocrine Therapy in Participants With Early Breast Cancer - EMBER-4 - Eli Lilly and CompanySee more
Gedatolisib Plus Fulvestrant With or Without Palbociclib vs Standard-of-Care for the Treatment of Patients With Advanced or Metastatic HR+/HER2- Breast Cancer (VIKTORIA-1) - VIKTORIA-1 - Celcuity, Inc.See more
Lymphoma
An Open-Label Study Comparing Glofitamab and Polatuzumab Vedotin + Rituximab, Cyclophosphamide, Doxorubicin, and Prednisone Versus Pola-R-CHP in Previously Untreated Patients With Large B-Cell Lymphoma - GO44145 - Hoffmann-La RocheSee more
A Dose-Escalation and Expansion Study of BGB-16673 in Participants With B-Cell Malignancies - CaDAnCe-101 - BeiGeneSee more
Multiple myeloma
A Study Comparing Teclistamab Monotherapy Versus Pomalidomide, Bortezomib, Dexamethasone (PVd) or Carfilzomib, Dexamethasone (Kd) in Participants With Relapsed or Refractory Multiple Myeloma - MajesTEC-9 - Janssen Research & Development, LLCSee more
MagnetisMM-32: A Study to Learn About the Study Medicine Called Elranatamab in People With Multiple Myeloma (MM) That Has Come Back After Taking Other Treatments (Including Prior Treatment With an Anti-CD38 Antibody and Lenalidomide) - MagnetisMM-32 - PfizerSee more
Bladder Cancer
Safety and Efficacy Study of Intravesical Instillation of TARA-002 in Adults With High-grade Non-muscle Invasive Bladder Cancer - ADVANCED-2 - Protara TherapeuticsSee more
Head and neck cancer
A Study to Test Whether Treatment With BI 770371 in Combination With Pembrolizumab With or Without Cetuximab Helps People With Head and Neck Cancer Compared With Pembrolizumab Alone - Boehringer IngelheimSee more
Lung cancer
A Study of Repotrectinib Versus Crizotinib in Participants With Locally Advanced or Metastatic Tyrosine Kinase Inhibitor (TKI)-naïve ROS1-positive Non-Small Cell Lung Cancer (NSCLC) (TRIDENT-3) - TRIDENT-3 - Zai Lab (Shanghai) Co., Ltd.See more
Prostate cancer
A Phase 2 Trial of Darolutamide as a Prostate-Specific Membrane Antigen (PSMA) Expression Enhancer in Patients With Localized Prostate Cancer - Darolutamide - D'Or Institute for Research and EducationSee more
Rare diseases
A Dose-Escalation and Expansion Study of BGB-16673 in Participants With B-Cell Malignancies - CaDAnCe-101 - BeiGeneSee more
